Inhibition of estrogen receptor function promotes porcine coronary artery smooth muscle cell proliferation

Mark C. Lavigne, Peter W. Ramwell, Robert Clarke

Research output: Contribution to journalArticle

11 Scopus citations

Abstract

Estradiol-17β (E2) can inhibit vascular smooth muscle cell (VSMC) proliferation probably through its ability to activate its nuclear estrogen receptors (ER). Activation or inhibition of the ER by cognate permissive or non-permissive ligands, respectively, would indicate whether ER action is critical for this vascular protective effect. We investigated a previously characterized population of cultured porcine coronary artery SMCs for ER expression and for the response of these cells to estrogens and antiestrogens. Reverse transcription-polymerase chain reaction and Western blot analyses demonstrated ER mRNA and protein, respectively, in these cells. While the culture conditions required may have prevented the demonstration of physiological effects of E2, the antiestrogens, ICI 182,780 and 4- hydroxytamoxifen, stimulated VSMC proliferation. The data suggest that, by interrupting ER function, antiestrogens significantly increased the VSMC mitotic rate. This model may be used to identify ER-regulated genes that function to control the growth of these coronary artery SMCs.

Original languageEnglish (US)
Pages (from-to)472-480
Number of pages9
JournalSteroids
Volume64
Issue number7
DOIs
StatePublished - Jul 1999
Externally publishedYes

Keywords

  • Antiestrogen
  • Coronary
  • Estrogen
  • Estrogen receptor
  • Smooth muscle
  • Steroid

Fingerprint Dive into the research topics of 'Inhibition of estrogen receptor function promotes porcine coronary artery smooth muscle cell proliferation'. Together they form a unique fingerprint.

  • Cite this